Atrial Fibrillation During an Exploration Class Mission by Polk, James et al.
Atrial Fibrillation During an 
Exploration Class Mission
Mark Lipsett MD, PhD
Douglas Hamilton MD, PhD
Jay Lemery MD
James Polk DO
https://ntrs.nasa.gov/search.jsp?R=20110010926 2019-08-30T15:19:49+00:00Z
Disclosure Information
82nd Annual Scientific and Human Performance Meeting
Mark Lipsett, Douglas Hamilton, Jay Lemery, James Polk
Have no financial relationships to disclose
The authors will not discuss off-label use and/or 
investigational use in this presentation
Outline
1 Background
5 Distant Medical Management
2 Causes of Atrial Fibrillation
3 Mission to Mars
4 Medical Resources
6 Mission Summary
Outline
1 Background
Mission Background
* After a several month journey, the 7-member crew 
is preparing to enter a low Mars orbit
* You, the flight surgeon, have just received the 
mission commander’s video message 
supplemented with the crew’s biometrics & health 
status
* The message, delayed by the 20 min
transmission lag, confirms the “return to
duty” criteria for mission specialist (M.C.)
1
Medical Background 1
* M.C. indicated feeling a strange “fluttering” & 
“pressure” in his chest during these bouts
*
M.C., a 51-yo mission scientist had presented 2 
months earlier via a “store & forward” PMC with the 
chief complaint of Cardiac Palpitations
Three episodes, lasting ~3hr & terminating with bed 
rest, were diagnosed as Paroxysmal Atrial 
Fibrillation (PAF)
*
Medical Background
* M.C.’s cardiac exam 30 days before mission take-
off indicated:  ø CAD risk factors
ø cardiac Ca2+ score
ø significant ectopy during Holter
1
Medical Background
* M.C.’s cardiac exam 30 days before mission take-
off indicated:  ø CAD risk factors
ø cardiac Ca2+ score
ø significant ectopy during Holter
* EKG obtained during all three PAF episodes 
revealed 
AF with:   ventricular rate of ~150 bpm
narrow complex QRS
ø ST- or T-wave abnormalities
1
Medical Background
* EKG obtained during all 3      episodes revealed 
with:   ventricular rate of ~150 bpm
narrow complex QRS
ø ST- or T-wave abnormalities
PAF
AF
1
Medical Background
* M.C.’s cardiac exam 30 days before mission take-
off indicated:  ø CAD risk factors
ø cardiac Ca2+ score
ø significant ectopy during Holter
*
* M.C. indicated having an URTI 3 weeks before the 
first bout of      in which
was used and a slight                 was noted
PAF pseudo-ephedrine 
hand tremor
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Medical Background
AF & the Astronaut Corps
* Of significance is the younger age (~40s) in which 
these arrhythmias are detected (vs >60 years)
* Due to: better health surveillance?
higher vagal tone?
random chance?
gravitational-flux induced?
*
Since 1950s, 17 cases of AF have been diagnosed 
amongst 317 active & retired astronauts (~5%)
* Since 2001, 5 astronauts underwent RFA treatment 
for atrial arrhythmias
1
Medical Background
AF & the Astronaut Corps
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2 Causes of Atrial Fibrillation
Terrestrial Mechanisms
of Atrial Fibrillation
* Structural Heart Disease
*
Pericarditis
* Metabolic Disturbances
* Ectopic Beats
*
Myocardial Stretch
* Idiopathic
2
Mission Question 1:
What Caused M.C.’s AF?
a CO poisoning
b Cardiomyopathy
Iatrogenicc
Idiopathic AF (lone AF)d
Myocardial infarctione
Pericarditisf
Post-viral thyrotoxicosisg
Pulmonary embolismh
Structural i
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Mission Question 1:
What Caused M.C.’s AF?
Idiopathic AF (lone AF)d
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3 Mission to Mars
Continuation of Mission
* The space vehicle is preparing to fire it’s engines to 
enter a parking orbit around Mars
* Any chance of returning to Earth in less than 1 year 
is impossible
3
Mission Question 2:
At this point you decide to...
a continue mission, watchful waiting, EKG when 
symptomatic
b Abort mission due to poor prognosis & risk of 
thromboembolic event
continue mission, start ASA daily with bi-monthly 
EKG follow-up exams
c
continue mission, start a β-blocker for possible 
thyrotoxic disease
d
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4 Medical Resources
The Mission at Home
* The last few weeks have been a harrowing 
experience for you as the mission Flight Surgeon
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The Mission at Home
* The last few weeks have been a harrowing 
experience for you as the mission Flight Surgeon
* You have organized an international aerospace 
cardiology expert panel to decide:
• abort mission, sling-shot burn around Mars and 
return to Earth within 6 months
• continuing with the Mars landing and subsequent 
1-year surface endeavour
4
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Crew Supplies
* Adequate ASA for the whole mission
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The Mission at Home
Crew Supplies
* Adequate ASA for the whole mission
* Insufficient anti-coagulation, rate-control & rhythm 
control medications for one astronaut
* An Automatic External Defibrillator (AED) device
4
Mission Question 3:
Inquest
a ASA is just as effective as warfarin for anti-
coagulation
b the risks and difficulty monitoring warfarin therapy 
outweigh the stroke risk reduction
low-molecular weight heparin is not effective in 
treating thromboembolic risks associated with AF
c
Immediate electrical cardioversion would preclude 
the need for anticoagulation
d
In your testimony to the international experts’ 
conference, you state that:
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The Mission at Home
Inquest
* At the experts’ panel, you present an extensive pre-
mission risk/benefit study analysis:
long-duration mission profile
age and excellent health of crew
risk of lone AF and subsequent crew member impact, 
including fatal stroke
* Conclusions: 
impact & risk of warfarin therapy > ASA therapy
* At time of mission planning, newer direct thrombin 
inhibitors not yet vetted
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Distant Medical Management
Continuation of Mission
* Their Mars surface mission proceeded uneventfully 
until ~1 year after landing when M.C. noticed 24 
hours of persistent palpitations, just 3 days before 
scheduled lift-off & return
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* M.C. notes feeling uncomfortable, but denies chest 
pressure or dyspnea
Mission Question 4:
At this point, you would recommend:
a Nothing, M.C. can be expected to spontaneously 
convert to NSR in the next 24 hours
b Rate control and reassess
Rate control and initiate immediate chemical 
cardioversion
c
Immediate electrical cardioversion due to 
hypotension
d
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* Rate control first choice, AF can ↓ ventricular filling 
by ~20%
* Ca
2+ channel blocker vs β-blocker, side-effects
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)
* Rate control first choice, AF can ↓ ventricular filling 
by ~20%
* Ca
2+ channel blocker vs β-blocker, side-effects
* Electrical cardioversion only when symptomatic
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Continuation of Mission
* Crew member M.C. continued to take ASA and was 
acutely rate controlled with Ca2+ CB
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* Crew member M.C. continued to take ASA and was 
acutely rate controlled with Ca2+ CB
* M.C. remained in NSR for the duration of the 
journey back to Earth and the mission was 
completed successfully
Continuation of Mission
6
* Of interest was his conversion back to NSR during 
the 4 minutes of 3Gx loading during lift off from the 
Martian surface
Summary
* This case was to acquaint the audience with the 
tremendous challenges that face the flight surgeon 
and medical team when supporting a space mission
Summary
* This case was to acquaint the audience with the 
tremendous challenges that face the FS and 
medical team when supporting a space mission
* Limited crew training time, medical hardware & 
pharmaceuticals manifested dictate aggressive 1 & 
2 prevention strategies to protect a multi-
billion dollar asset like the ISS or a
mission to the Moon or Mars
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